Real-time enrollment status for this peanut allergies clinical trial
Current Status
Recruiting
Checked: October 13, 2026 at 12:07 AM UTC
| NCT Number | NCT07287033 |
| Recruiting Status | Recruiting |
| Condition | Peanut Allergies |
| Phase | PHASE1 |
| Target Enrollment | 48 participants |
| Active Locations | 9 sites in the US |
| Sponsor | Mabylon AG |
| Last Updated on CT.gov | August 25, 2026 (Aug 25, 2026) |
As of October 13, 2026: Clinical trial NCT07287033 is currently recruiting participants. This phase1 study for peanut allergies is actively seeking new participants at 9 locations across the United States. The study is sponsored by Mabylon AG. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07287033 is actively recruiting participants as of October 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07287033 was last updated Aug 25, 2026 (August 25, 2026). HelloStudys verifies this status automatically.